Boulding Mark Elliott

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
38
Insider Sells Sum
$27.41M

Insider Activity of Boulding Mark Elliott

According to the SEC Form 4 filings, Boulding Mark Elliott, being in a position of

  1. EXEC. VP AND CLO at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 273944 shares for $14.44M,
    over all time since 2014-03-20, has bought 0 shares, and sold 527324 shares for $27.41M.

The largest sale of all time was on 2024-12-02 and amounted to 85600 shares of PTC Therapeutics, Inc. for $4.47M.

Biography of Boulding Mark Elliott

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $000
Sells
 $14,441,09813100

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2025-03-12SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
15,521
0.0196%
$53.30$827,233+2.26%
2025-03-11SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,719
0.0022%
$53.01$91,124+1.94%
2025-03-11SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
7,381
0.0094%
$53.02$391,323+1.94%
2025-03-10SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
60,277
0.0773%
$53.09$3.2M+1.32%
2025-03-10SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
68,039
0.0872%
$53.09$3.61M+1.32%
2025-02-20SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,614
0.0021%
$50.12$80,900+4.62%
2025-02-19SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,333
0.0018%
$50.10$66,778+3.93%
2025-01-08SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,998
0.0026%
$44.50$88,911+10.8%
2025-01-07SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,543
0.002%
$45.34$69,960+11.68%
2024-12-03SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
8,903
0.0122%
$53.14$473,114-4.45%
2024-12-03SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
9,708
0.0133%
$53.28$517,231-4.45%
2024-12-03SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
10,308
0.0141%
$53.26$549,055-4.45%
2024-12-02SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
85,600
0.1098%
$52.26$4.47M-7.7%
2024-01-30SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
794
0.0011%
$27.25$21,637+29.48%
2024-01-09SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,938
0.0026%
$29.01$56,231+17%
2024-01-08SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,457
0.0019%
$28.64$41,729+11.97%
2023-04-17SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
61,923
0.0836%
$51.42$3.18M-44.11%
2023-01-31SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
812
0.0011%
$45.63$37,050-12.4%
2023-01-11SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
495
0.0007%
$44.36$21,958-10.8%
2023-01-10SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
590
0.0008%
$42.93$25,330-7.73%
Total: 38
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD